The Pancreatic Cancer Collective (PCC) is an initiative of the Lustgarten Foundation and Stand Up To Cancer to improve pancreatic cancer patient outcomes.

The Parker Institute for Cancer Immunotherapy (PICI) @ Stanford Medicine Bedside to Bench Grant Program supports early stage projects that will enhance interdisciplinary basic and translational research among the Stanford scientific community in Cancer Immunotherapy.

For over two decades, Gabrielle’s Angel Foundation has provided significant financial support to some incredibly promising physician scientists, who are applying novel and state-of-the-art techniques to address fundamental problems in the genesis and treatment of blood related cancers.

The Pancreatic Cancer Collective (an initiative of the Lustgarten Foundation and Stand Up To Cancer) is announcing a new funding initiative that represents a focused effort on increasing the number of innovative and effective therapies to treat pancreatic cancer.

The Stanford Cancer Institute (SCI) solicits applications for Pancreatic Cancer Innovation Projects. SCI seeks innovative proposals that have a high likelihood of leading to external funding, new clinical interventions, new intellectual property, or other clear measures of success.